← Back to Search

RADPAD for Nuclear Radiation Emergency

N/A

Recruiting

Led By Giorgio A. Medranda, MD

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from start of each procedure until end of each procedure (up to 1 day)

Awards & highlights

Study Summary

This trial will study the effects of using RADPAD in cardiac catheterization procedures on operators in a large group of patients and operators. The study will compare the radiation exposure of operators using RADPAD with

Who is the study for?

The ATTENUATE trial is for healthcare professionals like physician assistants, cardiology fellows, and interventional cardiologists who perform cardiac catheterization procedures at NYU Langone Hospital - Long Island. Participants must be over 18 years old and able to give consent.Check my eligibility

What is being tested?

This study tests the RADPAD's effectiveness in reducing radiation exposure to medical staff during heart-related catheterization procedures. It involves comparing standard radiation safety measures with and without the use of RADPAD in a large-scale, randomized controlled trial.See study design

What are the potential side effects?

Since this trial focuses on protective equipment (RADPAD) rather than medication, there are no direct side effects for participants as it aims to reduce their exposure to harmful radiation.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from start of each procedure until end of each procedure (up to 1 day)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from start of each procedure until end of each procedure (up to 1 day)

This trial's timeline: 3 weeks for screening, Varies for treatment, and from start of each procedure until end of each procedure (up to 1 day) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

OE/DAP (uSv/mGy*cm2) of the proximal operator in which only guideline directed radiation protocols were utilized

Operator exposure (OE)/dose area product (DAP) (uSv[micro-Sieverts]/mGy[milligray]*cm2) of the proximal operator in which guideline directed radiation protocols and the RADPAD was utilized

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: RADPADExperimental Treatment1 Intervention

Each cardiac catheterization procedure utilizes the standard guideline directed radiation protocol and a single RADPAD will be placed on the patient. All employee participants will wear a radiation detection device at the level of the left side of the chest facing the radiation source over any the protective apron worn by the participant.

Group II: No RADPADActive Control1 Intervention

Each cardiac catheterization procedure utilizes the standard guideline directed radiation protocol and no RADPAD will be used. All employee participants will wear a radiation detection device at the level of the left side of the chest facing the radiation source over any the protective apron worn by the participant.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor

1,369 Previous Clinical Trials

840,498 Total Patients Enrolled

Giorgio A. Medranda, MDPrincipal InvestigatorNYU Langone Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research actively seeking participants at the moment?

"Indeed, information on clinicaltrials.gov confirms the ongoing recruitment for this research. The trial was initially listed on February 1st, 2024 and last modified on March 4th, 2024. Enrollment of about a hundred participants is sought from one designated site."

Answered by AI

What is the upper limit for patient participation in this particular research endeavor?

"Indeed, as per clinicaltrials.gov, this study is actively enrolling participants. It was first listed on February 1st, 2024 and the most recent update was made on March 4th, 2024. The trial aims to recruit a total of 100 patients from one designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

ATTENUATE (rAdpad proTecTion drapE iN redUcing rAdiaTion Exposure) Trial

2024. "ATTENUATE (rAdpad proTecTion drapE iN redUcing rAdiaTion Exposure) Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06233578.